BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19914029)

  • 21. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
    Johansen M
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2802-4. PubMed ID: 17086221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
    Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
    Moayyedi P; Sadowski DC
    Can J Gastroenterol; 2009 Apr; 23(4):251-2. PubMed ID: 19373416
    [No Abstract]   [Full Text] [Related]  

  • 25. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
    Gellatly RM; Ackman ML
    Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
    Cryer B
    N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
    [No Abstract]   [Full Text] [Related]  

  • 27. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations.
    Abraham NS
    Curr Opin Gastroenterol; 2011 Oct; 27(6):558-64. PubMed ID: 22001826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm?
    Laine L
    Gastroenterology; 2011 Mar; 140(3):769-72. PubMed ID: 21266209
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
    Ma B; Hang L; Chen G; Du Y
    West Indian Med J; 2013 Feb; 62(2):135-9. PubMed ID: 24564063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
    Kim JH
    Korean J Gastroenterol; 2011 Apr; 57(4):205-6. PubMed ID: 21519172
    [No Abstract]   [Full Text] [Related]  

  • 33. [Economic evaluation of the treatment with aspirin plus esomeprazole compared to clopidogrel in gastrointestinal bleeding prevention].
    Piñol C
    Gac Sanit; 2006; 20(1):54-7. PubMed ID: 16539994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
    Morneau KM; Reaves AB; Martin JB; Oliphant CS
    J Manag Care Pharm; 2014 Feb; 20(2):187-93. PubMed ID: 24456320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
    Kasprzak M; Koziński M; Bielis L; Boinska J; Plazuk W; Marciniak A; Budzyński J; Siller-Matula J; Rość D; Kubica J
    Cardiol J; 2009; 16(6):535-44. PubMed ID: 19950090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y; Suzuki H; Umetsu R; Uranishi H; Abe J; Nishibata Y; Sekiya Y; Miyamura N; Hara H; Tsuchiya T; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(5):680-6. PubMed ID: 25947914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel with or without omeprazole in coronary disease.
    Sadek A; Ford AC
    N Engl J Med; 2011 Feb; 364(7):681; author reply 682-3. PubMed ID: 21323549
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of clopidogrel and omeprazole.
    Southworth MR; Temple R
    N Engl J Med; 2010 Nov; 363(20):1977. PubMed ID: 21067412
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
    Vardi M; Cryer BL; Cohen M; Lanas A; Schnitzer TJ; Lapuerta P; Goldsmith MA; Laine L; Doros G; Liu Y; McIntosh AI; Cannon CP; Bhatt DL
    Aliment Pharmacol Ther; 2015 Aug; 42(3):365-74. PubMed ID: 26032114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal bleeding after percutaneous coronary intervention.
    Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.